Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Oncology Letters|July 30, 2020
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinomaTomoki Kohno, Asahiro Morishita, Hisakazu Iwama, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
HbA1c of 5.8% or higher as the most useful indicator for recommendation of ultrasonography to detect nonalcoholic fatty liver diseaseMiwa Tatsuta, Masafumi Ono, Shungo Kimura, et al.
Hepatology International|December 30, 2022
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter studyAsahiro Morishita, Kyoko Oura, Kei Takuma, et al.
Molecular Cancer Therapeutics|January 7, 2012
The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivoKiyohito Kato, Jian Gong, Hisakazu Iwama, et al.
Oncology Letters|February 3, 2018
Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next-generation sequencingAsahiro Morishita, Hisakazu Iwama, Shintaro Fujihara, et al.
Oncology Reports|July 7, 2020
Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosisTingting Shi, Koji Fujita, Jian Gong, et al.
Oncology Letters|February 13, 2016
Successful mucosal incision-assisted biopsy for the histological diagnosis of duodenal lymphoma: A case reportAsahiro Morishita, Hirohito Mori, Hideki Kobara, et al.
International Journal of Oncology|June 29, 2017
Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro studyTomoko Tadokoro, Shintaro Fujihara, Taiga Chiyo, et al.
Oncology Letters|February 22, 2021
Association between microRNA-527 and glypican-3 in hepatocellular carcinomaKei Nomura, Akira Kitanaka, Hisakazu Iwama, et al.
Cancers|June 28, 2023
Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination TherapyKyoko Oura, Asahiro Morishita, Takushi Manabe, et al.
Pageof 16